- Home
- LOB vs HRMY Comparison
LOB vs HRMY Comparison
Compare LOB & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOB
- HRMY
- Stock Information
- Founded
- LOB 2008
- HRMY 2017
- Country
- LOB United States
- HRMY United States
- Employees
- LOB N/A
- HRMY N/A
- Industry
- LOB Major Banks
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- LOB Finance
- HRMY Health Care
- Exchange
- LOB Nasdaq
- HRMY Nasdaq
- Market Cap
- LOB 2.2B
- HRMY 2.1B
- IPO Year
- LOB 2015
- HRMY 2020
- Fundamental
- Price
- LOB $47.67
- HRMY $33.07
- Analyst Decision
- LOB Buy
- HRMY Buy
- Analyst Count
- LOB 6
- HRMY 9
- Target Price
- LOB $45.67
- HRMY $47.00
- AVG Volume (30 Days)
- LOB 249.2K
- HRMY 1.3M
- Earning Date
- LOB 10-23-2024
- HRMY 10-29-2024
- Dividend Yield
- LOB 0.25%
- HRMY N/A
- EPS Growth
- LOB 39.66
- HRMY N/A
- EPS
- LOB 1.84
- HRMY 2.11
- Revenue
- LOB $405,743,000.00
- HRMY $681,879,000.00
- Revenue This Year
- LOB N/A
- HRMY $24.63
- Revenue Next Year
- LOB $16.54
- HRMY $18.04
- P/E Ratio
- LOB $25.93
- HRMY $15.71
- Revenue Growth
- LOB 9.13
- HRMY 25.83
- 52 Week Low
- LOB $31.03
- HRMY $27.11
- 52 Week High
- LOB $50.57
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- LOB 55.41
- HRMY 43.68
- Support Level
- LOB $47.67
- HRMY $32.55
- Resistance Level
- LOB $49.19
- HRMY $36.68
- Average True Range (ATR)
- LOB 1.56
- HRMY 1.68
- MACD
- LOB 0.54
- HRMY -0.11
- Stochastic Oscillator
- LOB 75.31
- HRMY 29.37
About LOB Live Oak Bancshares Inc.
Live Oak Bancshares Inc operates as the bank holding company for the Live Oak Banking Company. The company specializes in lending and deposit-related services to small businesses nationwide. The company identifies and extends lending to credit-worthy borrowers both within specific industries, also called verticals, through expertise within those industries, and more broadly to select borrowers outside of those industries. A portion of the loans originated by the Bank are partially guaranteed by the Small Business Administration under the 7(a) Loan Program and the U.S. Department of Agriculture Rural Energy for America Program, Water and Environmental Program, Business and Industry and Community Facilities loan programs.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.